Novartis-Roche condannate in Italia

Avrebbero creato un cartello dicono i giudici (euronews)

Su altre testate

Novartis has filed its ophthalmology drug brolucizumab with the US regulator, a potentially strong competitor in the tough market for drugs for the degenerative eye condition wet AMD. (pharmaphorum)